US Stock Market Move | Optimi Health (OPTH.US) debuts on the US stock market with an opening price drop of over 13%.
Optimi Health has entered the US stock market, with its opening price dropping by more than 13%, at $6.1 per share.
On Wednesday, Optimi Health (OPTH.US) made its debut on the US stock market, with the opening price falling over 13% to $6.1. The IPO price was $7.05. Optimi Health is a pharmaceutical company from Canada, focusing on the production of MDMA and Psilocybin drug products for mental health treatment. The company is headquartered in British Columbia, Canada, and has a GMP drug production facility licensed by Health Canada.
Related Articles
DEEPEXI TECH (01384) plans to discount approximately 19.78% of the placement of 7.942 million new H shares, raising approximately HK$395 million net.
JENSCARE-B(09877): The 12-month clinical follow-up results of patients with large valve disease who received the LuX-Valve Plus EU TRINITY research will be released at EuroPCR 2026, demonstrating the advantages of the product's large size.
New stock news | Zoomlion Heavy Industry submits an application to the Hong Kong Stock Exchange again as a mining equipment and aerial work equipment company.
DEEPEXI TECH (01384) plans to discount approximately 19.78% of the placement of 7.942 million new H shares, raising approximately HK$395 million net.
JENSCARE-B(09877): The 12-month clinical follow-up results of patients with large valve disease who received the LuX-Valve Plus EU TRINITY research will be released at EuroPCR 2026, demonstrating the advantages of the product's large size.
New stock news | Zoomlion Heavy Industry submits an application to the Hong Kong Stock Exchange again as a mining equipment and aerial work equipment company.
